Penang Medical College
George Town, 11450, Malaysia
NCT Number: NCT02845557
Early onset type 2 diabetes mellitus among adolescents/youth (YT2DM) is a rising phenomenon. The pathophysiology has been studied primarily on non-Asian populations while literature on incretin effect is scarce. The investigators evaluated insulin sensitivity, beta-cell function, incretin hormones and their effect in YT2DM from a multiethnic Malaysian population. The characterization of this population may enable us to better tailor their antidiabetic care.
Looking for future studies?
Notify Me10 year–25 year
All sexes
Observational
George Town, 11450, Malaysia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
This is a cross sectional study where the outcome was measured whenever the test was conducted.
Time frame: 1 year
This is a cross sectional study where the outcome was measured whenever the test was conducted.
Time frame: 1 year
This is a cross sectional study where the outcome was measured whenever the test was conducted.
Time frame: 1 year
This is a cross sectional study where the outcome was measured whenever the test was conducted.
Time frame: 1 year
It is estimated by relating the differences in beta cell responses from C peptide between stimulation with oral and intravenous glucose. The incretin effect is estimated by the formula 100 ×(BCOG BCIV)/BCOG).
RCSI & UCD Malaysia Campus
Other
Glucose Homeostasis, Incretin Effect and Cardiovascular Risk Burden in T2DM in the Youth- a Study of the Malaysian Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00445627
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT01878045
Diabetes Complications, Diabetes Mellitus
Phoenix, Arizona, United States
View Trial DetailsNCT06326047
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chula Vista, California, United States
View Trial DetailsNCT06423729
Body Weight, Diabetes Mellitus
Tanta, Egypt
View Trial Details